Medtronic Shores Up Tissue Valve Portfolio With ATS Medical Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Medtronic will expand its pericardial tissue heart valve offerings and further strengthen its cardiovascular business through its $370 million acquisition of ATS Medical, announced April 29
You may also be interested in...
People Briefs: GI Dynamics CEO; Allergan CFO; HeartFlow Changes
New CEO for GI Dynamics. Allergan names Jim Hindman CFO. HeartFlow makes executive suite changes; Biogen Idec appoints new executive VP.
Medtronic’s Hawkins To Retire; Company Sets External Search For New CEO
Medtronic Chairman and CEO William Hawkins is retiring after just three years in the firm’s top spot, a move that may reflect the company’s desire to accelerate change and diversification in the face of sluggish growth in signature businesses.
Medtronic’s Hawkins To Retire; Company Sets External Search For New CEO
Medtronic Chairman and CEO William Hawkins is retiring after just three years in the firm’s top spot, a move that may reflect the company’s desire to accelerate change and diversification in the face of sluggish growth in signature businesses.